Event Date/Time: Sep 20, 2004
End Date/Time: Sep 21, 2004
Successful new developments in cancer vaccine research, especially in exciting areas such as dendritic cell based vaccines, heat shock protein derived vaccines and T-cell responses, have immensely increased the opportunities for the design and development of new immunotherapeutics. This conference will focus on successful and novel strategies to overcome the hurdles of producing effective cancer vaccines. Topics will range from the design of novel immunotherapies, development of clinical studies and finally the challenges of commercialization.